Rockville, Maryland — September 24, 2026 — The global artificial intelligence in life sciences market is entering a period of broader enterprise adoption as pharmaceutical and life sciences organizations integrate artificial intelligence into drug discovery, clinical research, precision medicine, and regulatory workflows. According to a new Fact.MR analysis, the market is valued at...